Literature DB >> 29110279

Metoprolol, propranolol, carvedilol, or labetalol for patients with Takotsubo syndrome?

John E Madias1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29110279     DOI： 10.1007/s10286-017-0482-y

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


× No keyword cloud information.
  5 in total

1.  Plasma catecholamine levels in patients with takotsubo syndrome: Implications for the pathogenesis of the disease.

Authors:  Shams Y-Hassan; Loghman Henareh
Journal:  Int J Cardiol       Date:  2014-11-26       Impact factor: 4.164

2.  A proposal for a noninvasive monitoring of sympathetic nerve activity in patients with takotsubo syndrome.

Authors:  John E Madias
Journal:  Med Hypotheses       Date:  2017-10-07       Impact factor: 1.538

3.  Neurohumoral features of myocardial stunning due to sudden emotional stress.

Authors:  Ilan S Wittstein; David R Thiemann; Joao A C Lima; Kenneth L Baughman; Steven P Schulman; Gary Gerstenblith; Katherine C Wu; Jeffrey J Rade; Trinity J Bivalacqua; Hunter C Champion
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

4.  (123)I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy.

Authors:  Thomas Emil Christensen; Lia Evi Bang; Lene Holmvang; Dorthe Charlotte Skovgaard; Ditte Bang Oturai; Helle Søholm; Jakob Hartvig Thomsen; Hedvig Bille Andersson; Adam Ali Ghotbi; Nikolaj Ihlemann; Andreas Kjaer; Philip Hasbak
Journal:  JACC Cardiovasc Imaging       Date:  2016-06-22

Review 5.  Epidemiology, pathogenesis, and management of takotsubo syndrome.

Authors:  Shams Y-Hassan; Per Tornvall
Journal:  Clin Auton Res       Date:  2017-09-15       Impact factor: 4.435
  5 in total
  2 in total

1.  Reply to: metoprolol, or propranolol, or carvedilol, or labetalol, for patients with takotsubo syndrome?

Authors:  Shams Y-Hassan; Per Tornvall
Journal:  Clin Auton Res       Date:  2017-11-27       Impact factor: 4.435

2.  Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome.

Authors:  Albert Topf; Moritz Mirna; Christiane Dienhart; Peter Jirak; Nina Bacher; Elke Boxhammer; Sarah X Gharibeh; Lukas J Motloch; Uta C Hoppe; Michael Lichtenauer
Journal:  Biomedicines       Date:  2022-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.